Randomized trial shows melatonin reduces urinary 8-OHdG levels in night shift workers — Evidence Review
Published in Occupational & Environmental Medicine
Researched by
— the AI search engine for science
Table of Contents
Melatonin supplementation may enhance the body's ability to repair DNA damage linked to night shift work, according to a new randomized controlled trial; related studies broadly support melatonin's protective effect against oxidative DNA damage. Most prior research—including in vitro and animal studies—agrees that melatonin can boost DNA repair processes and reduce oxidative stress, although evidence from clinical trials in humans remains limited (1,2,4).
- Several studies demonstrate that melatonin can stimulate DNA repair pathways and protect against various forms of oxidative DNA damage, consistent with the new trial’s findings (1,2,4,7).
- The use of urinary 8-OHdG as a biomarker is validated in related research, though some studies caution that endogenous melatonin levels can confound interpretation in observational settings (13,15).
- While animal and cell-based studies show clear benefits, there is a scarcity of large-scale, long-term randomized controlled trials in diverse human populations, highlighting a gap that the new study begins to address (2,12).
Study Overview and Key Findings
Night shift work is increasingly recognized as a risk factor for certain cancers and other health issues, partly due to disruptions in circadian rhythms and melatonin production. Melatonin's role in DNA repair and protection against oxidative stress has been established in laboratory settings, but clinical evidence for its benefits among night shift workers is limited. This study provides new data on whether melatonin supplementation can counteract biological effects of night shift work in humans, focusing on biomarkers of DNA repair rather than clinical outcomes such as cancer incidence.
| Property | Value |
|---|---|
| Study Year | 2025 |
| Journal Name | Occupational & Environmental Medicine |
| Population | Night shift workers |
| Sample Size | 40 participants |
| Methods | Randomized Controlled Trial (RCT) |
| Outcome | Urinary levels of 8-OHdG, DNA repair capacity |
| Results | Urinary 8-OHdG levels were 80% higher in melatonin group. |
The study involved 40 night shift workers, randomized to receive either 3 mg of melatonin or placebo daily for 4 weeks. Melatonin supplementation led to an 80% increase in urinary 8-OHdG—a marker of DNA repair—during daytime sleep, but not during subsequent night shifts. The findings suggest melatonin may enhance DNA repair processes disrupted by night shift work, though the authors caution that larger, longer-term studies are needed before clinical recommendations can be made.
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus research database—which includes over 200 million scientific papers—using the following queries:
- melatonin DNA damage repair
- 8-OHdG levels melatonin effect
- melatonin oxidative stress urinary biomarkers
The most relevant themes and findings from the related studies are summarized below:
| Topic | Key Findings |
|---|---|
| How does melatonin affect DNA repair and oxidative stress? | - Melatonin and its metabolites protect cells from oxidative DNA damage and enhance DNA repair capacity through multiple pathways, including NRF2 activation and free radical scavenging (1,2,4,5,7,10). - Melatonin supplementation significantly improves oxidative stress parameters in clinical and experimental settings (6,12). |
| What is the clinical evidence for melatonin's protective effects in humans? | - Melatonin reduces urinary markers of oxidative stress and DNA damage in both animal and human studies, though most clinical data are from small or short-term trials (6,11,12). - Evidence for translation into reduced cancer risk or other long-term outcomes is still lacking; most studies focus on biomarkers rather than disease endpoints (12). |
| How should urinary 8-OHdG and melatonin metabolites be used as biomarkers? | - Urinary 8-OHdG is a widely used marker of oxidative DNA damage and repair, but its interpretation can be confounded by endogenous melatonin levels and environmental factors (13,15). - Simultaneous measurement of 8-OHdG and 6-sulfatoxymelatonin can provide valuable insights into oxidative stress and the role of melatonin (15). |
| What are the mechanisms by which melatonin protects against oxidative DNA damage? | - Melatonin acts through direct radical scavenging, upregulation of antioxidative enzymes, and activation of DNA repair pathways (e.g., NRF2, base-excision repair, and other repair machinery) (1,2,3,4,5,7,10). - Some studies indicate that melatonin’s stimulation of DNA repair does not rely on classic membrane receptors and may involve gene expression changes (1,2). |
How does melatonin affect DNA repair and oxidative stress?
A large body of laboratory research supports the idea that melatonin protects cells from oxidative DNA damage and enhances DNA repair capacity. These effects are observed across various cell types and experimental models, using different measures of damage and repair.
- Melatonin and its metabolites reduce oxidative DNA damage and stimulate the expression of protective enzymes via activation of NRF2-dependent pathways (1,10).
- Studies in cancer cell lines and animal models show that melatonin exposure is linked to increased DNA repair activity and altered expression of DNA repair genes (2,5).
- Melatonin’s antioxidative properties include direct free radical scavenging and indirect effects, such as boosting the DNA repair machinery (4).
- In human skin and reproductive tissues, melatonin prevents the formation of 8-OHdG, a biomarker of oxidative DNA damage (6,7).
What is the clinical evidence for melatonin's protective effects in humans?
While most evidence for melatonin’s DNA repair benefits comes from laboratory or animal studies, several small clinical and experimental studies in humans report reduced oxidative stress markers following melatonin supplementation. However, these studies are generally limited in sample size, duration, or population diversity.
- Melatonin supplementation (3 mg/day) reduced urinary 8-OHdG and improved oocyte quality in women undergoing IVF, indicating clinical relevance for DNA damage repair (6).
- In diabetic rats, melatonin decreased urinary markers of renal oxidative damage, pointing to its potential for reducing organ-specific oxidative stress (11).
- Meta-analyses of randomized controlled trials confirm improvements in various oxidative stress parameters with melatonin, but call for larger, well-designed studies to confirm these effects in broader human populations (12).
- Most clinical studies focus on biomarkers rather than hard endpoints, such as cancer incidence or chronic disease progression (12).
How should urinary 8-OHdG and melatonin metabolites be used as biomarkers?
Urinary 8-OHdG is frequently used to assess oxidative DNA damage and repair activity, but its levels can be influenced by endogenous melatonin and other factors. Related studies emphasize the importance of controlling for melatonin metabolites when interpreting 8-OHdG data.
- Natural variations in melatonin levels can confound associations between environmental exposures and urinary 8-OHdG, highlighting the need for careful study design in biomarker research (13).
- Simultaneous quantification of both urinary 8-OHdG and 6-sulfatoxymelatonin (a melatonin metabolite) can provide a more comprehensive assessment of oxidative stress and melatonin’s role in DNA repair (15).
- Some studies suggest measuring both markers together to better understand the pathophysiological pathways involved in oxidative stress and repair processes (15).
What are the mechanisms by which melatonin protects against oxidative DNA damage?
Mechanistic studies indicate that melatonin’s protective effects are multifaceted, involving both direct and indirect pathways.
- Melatonin directly scavenges reactive oxygen species and prevents DNA base modifications (3,4,5).
- It activates antioxidative gene expression (e.g., CAT, GPx, SOD) and prevents their depletion after oxidative stress (7,10).
- Melatonin upregulates DNA repair pathways, such as NRF2 signaling and possibly genes involved in base-excision repair (1,2,4).
- These protective actions can occur independently of classic melatonin membrane receptors, suggesting non-receptor-mediated mechanisms are also important (1).
Future Research Questions
While the new study adds to a growing body of evidence that melatonin supplementation may support DNA repair in night shift workers, important questions remain. Most notably, there is a need for larger, longer-term studies in diverse populations, investigation of clinical endpoints such as cancer risk, and a deeper understanding of the mechanisms and optimal use of biomarkers.
| Research Question | Relevance |
|---|---|
| Does long-term melatonin supplementation reduce cancer risk in night shift workers? | This question addresses whether the improvements in DNA repair capacity translate into reduced cancer incidence, a key concern for night shift workers and a gap not addressed in current short-term biomarker studies (12). |
| What are the optimal dose and duration of melatonin supplementation for DNA repair? | Determining the most effective and safe dosing regimen is critical for clinical recommendations, as current studies use varying doses and durations without clear consensus on best practice (12). |
| How do individual differences (e.g. age, sex, occupation) affect the response to melatonin supplementation? | Understanding variability in response is necessary to identify which populations may benefit most from supplementation, as most current studies focus on specific groups such as healthcare workers (6,12). |
| What mechanisms mediate melatonin’s effect on DNA repair in humans? | Further elucidation of the pathways involved (e.g., NRF2 activation, DNA repair gene upregulation) could improve the targeting and efficacy of interventions, and clarify differences between in vitro, animal, and human findings (1,2,4). |
| How should urinary 8-OHdG and melatonin metabolites be used together as biomarkers in clinical studies? | Integrating both markers may help avoid confounding and capture the complexity of oxidative stress and repair processes, improving the validity of biomarker-based research and clinical monitoring (13,15). |